Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2024-12-18

FDA Approved: DIMETHYL FUMARATE — Supplemental Application (SOLA Pharmaceuticals, LLC)

View source ↗

Summary

FDA approved a supplemental application for dimethyl fumarate from SOLA Pharmaceuticals, LLC, granting approval for its generic product under ANDA210436.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Dimethyl fumarate (Dimethyl fumarate)

Snippet

SUPPL AP for DIMETHYL FUMARATE (DIMETHYL FUMARATE)